Approval · Notice of Compliance 2460 · 2001
SYNAREL: Notice of Compliance 2460
Issued December 28, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2460
- Date
- December 28, 2001
- Company
- Pharmacia Canada Inc.Baie D'Urfe, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Gonadotropin releasing hormone (gnrh) analogue
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNAREL | 02188783 | Marketed |
Medicinal ingredients
- NAFARELIN ACETATE 2 MG per ML